Compare SLS & SRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLS | SRCE |
|---|---|---|
| Founded | 2012 | 1863 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.2B |
| IPO Year | 2007 | 1995 |
| Metric | SLS | SRCE |
|---|---|---|
| Price | $11.28 | $85.45 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 3 |
| Target Price | $32.50 | ★ $89.67 |
| AVG Volume (30 Days) | ★ 5.0M | 65.0K |
| Earning Date | 11-11-2026 | 10-22-2026 |
| Dividend Yield | N/A | ★ 2.04% |
| EPS Growth | ★ 50.00 | 19.59 |
| EPS | N/A | ★ 3.58 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $7.93 |
| Revenue Next Year | N/A | $2.93 |
| P/E Ratio | ★ N/A | $23.74 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.39 | $56.89 |
| 52 Week High | $15.88 | $91.46 |
| Indicator | SLS | SRCE |
|---|---|---|
| Relative Strength Index (RSI) | 49.35 | 36.48 |
| Support Level | $10.82 | $81.56 |
| Resistance Level | $15.77 | $84.48 |
| Average True Range (ATR) | 0.75 | 1.26 |
| MACD | 0.02 | -0.23 |
| Stochastic Oscillator | 79.10 | 0.11 |
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
1st Source Corp provides specialized financing services for construction equipment, aircraft, and vehicle types through its Specialty Finance activities. The company offers commercial, small business, agricultural, and real estate loans, along with commercial leasing, treasury management, and payment services, including Fedwires, ACH, and merchant services. It also provides Renewable Energy Financing for commercial solar projects, a full range of consumer banking products, Trust and Wealth Advisory Services, and insurance products. The company operates in the commercial banking segment, which provides commercial and consumer banking services, trust and wealth advisory services, and insurance to individual and business clients across its markets.